Patents by Inventor Stephen D. Nimer

Stephen D. Nimer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170016902
    Abstract: The present invention relates to methods and compositions for treating and reducing the risk of Acute Myelogenous Leukemia (AML). In particular, the invention provides methods for identifying novel treatments for AML based on reproducible and detectable changes in AMLI-ETO acetylation. The present invention further provides methods of using these treatments.
    Type: Application
    Filed: July 15, 2016
    Publication date: January 19, 2017
    Inventors: Stephen D. Nimer, Lan Wang
  • Patent number: 9435809
    Abstract: The present invention relates to methods and compositions for treating and reducing the risk of Acute Myelogenous Leukemia (AML). In particular, the invention provides methods for identifying novel treatments for AML based on reproducible and detectable changes in AML1-ETO acetylation. The present invention further provides methods of using these treatments.
    Type: Grant
    Filed: July 13, 2012
    Date of Patent: September 6, 2016
    Assignee: Memorial Sloan-Kettering Cancer Center
    Inventors: Stephen D. Nimer, Lan Wang
  • Publication number: 20140348840
    Abstract: The present invention relates to methods and compositions for treating and reducing the risk of Acute Myelogenous Leukemia (AML). In particular, the invention provides methods for identifying novel treatments for AML based on reproducible and detectable changes in AML1-ETO acetylation. The present invention further provides methods of using these treatments.
    Type: Application
    Filed: July 13, 2012
    Publication date: November 27, 2014
    Applicant: MEMORIAL SLOAN-KETTING CANCER CENTER
    Inventors: Stephen D. Nimer, Lan Wang